Navigation Links
Oncolab, Inc. Exhibits Pioneering AMAS Cancer Test at AACC
Date:7/28/2014

CHICAGO, July 28, 2014 /PRNewswire-iReach/ -- June 28th, 2014 – Oncolab, the Boston-based laboratory which has developed the AMAS cancer test, is making its AACC debut (booth #4051) at this year's conference in Chicago.  To date, the test, which is a serum-based in vitro immunoassay, has been run for over 60,000 patients and is emerging as a significant tool in the fight against cancer recurrence.

Photo - http://photos.prnewswire.com/prnh/20140728/130547

With an estimated 17 million cancer survivors in the US alone, the race is on to develop better technologies for identifying whether a cancer has begun to recur, and if so at what rate.  There is a clear trend towards the use of immunoassays in cancer diagnostics, as immunotherapy for treatment.  The AMAS test fits into these trends by measuring the level of a specific antibody, Anti-Malignin Antibody, which is thought to be produced by the body's immune system in response to nearly all forms of cancer.

Most other cancer immunoassays measure circulating levels of cancer antigens, which become elevated later than the antibody measured in the AMAS test.  As a result, the AMAS Test is an excellent aid to picking up recurrence at an early stage, since levels of anti-malignin antibody are often elevated early in the occurrence and recurrence of cancer.  This is a unique capability – false positive and false negative rates are under 10 percent.  While the AMAS Test does provide guidance as to the likely location of the cancer, new high-resolution imaging techniques such as MRI and CT, as well as more location-specific cancer tests, as well as clinical signs can help the clinician provide patients with the larger context.

Currently, Oncolab provides the test via submission of samples to its CLIA-certified laboratory in Boston, MA.  Serum samples must be shipped via overnight courier (FedEx, UPS or DHL) using a standardized shipping container and tubes provided at no cost by Oncolab, and dry ice obtained at the lab doing the blood draw and separation to serum.  The test is permitted to market by FDA, and reimbursed by Medicare.  Currently, the majority of samples being run are drawn in the US and Canada; overseas labs can also ship samples and are urged to contact Oncolab to get a technical and business relationship started.

The company is also working to develop a version of the test that can be run closer to the point of care; providers of new POC diagnostic platforms are encouraged to meet with the company's representatives at AACC to discuss possible development and deployment options.

Media Contact: Sarah Klein, Oncolab, Inc., 617-536-0850, sarah@oncolabinc.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Oncolab, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Talyst Exhibits at the National Association of State Veterans Homes Summer Conference
2. Varian Medical Systems Exhibits New Lightweight Wireless Flat-Panel Digital X-ray Image Detector for Imaging Extremities and for Neonatal Procedures
3. Varian Medical Systems Exhibits New Flat-Panel Digital X-ray Image Detectors Designed for High Energy Industrial and Security Applications
4. Kush Bottles Exhibits at Leading Industry Trade Show
5. BioDrain Medical Exhibits at National Registered Nurses Conference
6. Misonix Exhibits at Major Worldwide Spine Conference
7. Frost & Sullivan Applauds Check-Cap for Pioneering a Non-invasive, Prep-Free Wireless Capsule Endoscope
8. Pioneering Medical Device Patent Portfolio for Sale by ICAP Patent Brokerage
9. inVentiv Clinical Trial Recruitment Solutions Partners with Pioneering Firm to Revolutionize Clinical Trial Site Evaluation
10. Genocea Reports Positive Initial Phase 1/2a Results for GEN-003, its Pioneering Therapeutic Vaccine Candidate for the Treatment of Herpes Simplex Virus-2 (HSV-2), at ICAAC 2013
11. inVentiv Health Partner Mytrus Inc. Wins Prestigious Award For Its Pioneering Technology In Electronic Informed Consent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017  A new genetic test has been ... individuals who carry HLA-B*15:02 and who ... potentially deadly side effect of certain medications used ... HLA-B*15:02 is strongly associated with life-threatening ... and toxic epidermal necrolysis in patients treated with ...
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... devices market exhibits a consolidated vendor landscape with the ... the overall market in 2015. These companies are ... Industries, Inc., Hygia Health Services, Inc., and VANGUARD ... global reprocessed medical devices market is witnessing the ...
(Date:3/23/2017)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... it has acquired Agalimmune Ltd., a private UK-based company with ... $6 million upfront payment, of which $3 million is in ... may be made based on development and commercial milestones. ... Agalimmune,s lead ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... 23, 2017 , ... The Wound Certification Prep Course ... Holdings, LLC, today announced that RestorixHealth® has officially endorsed WCPC as ... interested in becoming Certified Wound Specialist Physicians (CWSP®). , This collaborative effort ...
(Date:3/23/2017)... ... 23, 2017 , ... Altec Products, Inc. , a ... their 2016 Microsoft Dynamics Partner of the Year at DocLink Evolution , ... recognizes The Resource Group for their outstanding relationship with Altec and their ability ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
(Date:3/23/2017)... ... March 23, 2017 , ... The ... facing life-altering and fatal diseases in opposition to the President’s Fiscal Year ... eviscerate care, services, and hope for the most vulnerable among us. , The ...
(Date:3/23/2017)... Marina del Rey, CA (PRWEB) , ... March ... ... version of its customizable coding audit software solution, iCode Assurance, at HCCA’s 21st ... iCode Assurance optimizes and accelerates the coding audit process for all medical chart ...
Breaking Medicine News(10 mins):